Present status of clofibrate therapy in ophthalmology

Br J Ophthalmol. 1969 Jan;53(1):9-15. doi: 10.1136/bjo.53.1.9.
No abstract available

MeSH terms

  • Aged
  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / therapeutic use*
  • Butyrates / adverse effects
  • Butyrates / therapeutic use*
  • Diabetic Retinopathy / drug therapy*
  • Eye Diseases / drug therapy*
  • Female
  • Glaucoma / drug therapy
  • Humans
  • Intraocular Pressure / drug effects
  • Lipidoses / drug therapy
  • Retinitis / drug therapy
  • Vascular Diseases / drug therapy

Substances

  • Anticholesteremic Agents
  • Butyrates